227 related articles for article (PubMed ID: 14751040)
1. Tablet formulation of levothyroxine is absorbed less well than powdered levothyroxine.
Yamamoto T
Thyroid; 2003 Dec; 13(12):1177-81. PubMed ID: 14751040
[TBL] [Abstract][Full Text] [Related]
2. Comparative bioavailability of two oral L-thyroxine formulations after multiple dose administration in patients with hypothyroidism and its relation with therapeutic endpoints and dissolution profiles.
Vaisman M; Spina LD; Eksterman LF; dos Santos MJ; Lima JS; Volpato NM; da Silva RL; de Brito AP; Noël F
Arzneimittelforschung; 2001; 51(3):246-52. PubMed ID: 11304941
[TBL] [Abstract][Full Text] [Related]
3. Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors.
Vita R; Saraceno G; Trimarchi F; Benvenga S
J Clin Endocrinol Metab; 2014 Dec; 99(12):4481-6. PubMed ID: 25259910
[TBL] [Abstract][Full Text] [Related]
4. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans.
Fish LH; Schwartz HL; Cavanaugh J; Steffes MW; Bantle JP; Oppenheimer JH
N Engl J Med; 1987 Mar; 316(13):764-70. PubMed ID: 3821822
[TBL] [Abstract][Full Text] [Related]
5. Comparison of TSH Levels with Liquid Formulation Versus Tablet Formulations of Levothyroxine in the Treatment of Adult Hypothyroidism.
Brancato D; Scorsone A; Saura G; Ferrara L; Di Noto A; Aiello V; Fleres M; Provenzano V
Endocr Pract; 2014 Jul; 20(7):657-62. PubMed ID: 24449674
[TBL] [Abstract][Full Text] [Related]
6. TSH Normalization in Bariatric Surgery Patients After the Switch from L-Thyroxine in Tablet to an Oral Liquid Formulation.
Fallahi P; Ferrari SM; Camastra S; Politti U; Ruffilli I; Vita R; Navarra G; Benvenga S; Antonelli A
Obes Surg; 2017 Jan; 27(1):78-82. PubMed ID: 27272506
[TBL] [Abstract][Full Text] [Related]
7. Levothyroxine absorption in health and disease, and new therapeutic perspectives.
Ianiro G; Mangiola F; Di Rienzo TA; Bibbò S; Franceschi F; Greco AV; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2014; 18(4):451-6. PubMed ID: 24610609
[TBL] [Abstract][Full Text] [Related]
8. Evidence for interference with the intestinal absorption of levothyroxine sodium by aluminum hydroxide.
Sperber AD; Liel Y
Arch Intern Med; 1992 Jan; 152(1):183-4. PubMed ID: 1728914
[TBL] [Abstract][Full Text] [Related]
9. Hypothyroidism in adults. Levothyroxine if warranted by clinical and laboratory findings, not for simple TSH elevation.
Prescrire Int; 2015 Oct; 24(164):241-4, 246. PubMed ID: 26594730
[TBL] [Abstract][Full Text] [Related]
10. Intestinal absorption and buccal absorption of liquid levothyroxine.
Benvenga S; Di Bari F
Endocrine; 2017 Dec; 58(3):591-594. PubMed ID: 28271396
[No Abstract] [Full Text] [Related]
11. In vitro dissolution and in vivo bioavailability of commercial levothyroxine sodium tablets in the hypothyroid dog model.
Wood RW; Martis L; Gillum AW; Roseman TJ; Lin L; Bernardo P
J Pharm Sci; 1990 Feb; 79(2):124-7. PubMed ID: 2324959
[TBL] [Abstract][Full Text] [Related]
12. Levothyroxine in psychiatry: issues related to absorption after oral dosing.
Andrade C
J Clin Psychiatry; 2013 Aug; 74(8):e744-6. PubMed ID: 24021514
[No Abstract] [Full Text] [Related]
13. Impaired enteral levothyroxine absorption in hypothyroidism refractory to oral therapy after thyroid ablation for papillary thyroid cancer: case report and kinetic studies.
Tönjes A; Karger S; Koch CA; Paschke R; Tannapfel A; Stumvoll M; Fuhrer D
Thyroid; 2006 Oct; 16(10):1047-51. PubMed ID: 17042692
[TBL] [Abstract][Full Text] [Related]
14. How do you approach the problem of TSH elevation in a patient on high-dose thyroid hormone replacement?
Morris JC
Clin Endocrinol (Oxf); 2009 May; 70(5):671-3. PubMed ID: 19226259
[TBL] [Abstract][Full Text] [Related]
15. [Primary hypothyroidism: Considerations for a rational use of levothyroxine therapy].
Bros JA; Lluís PG; Cabot GL; Pedragós AC
Med Clin (Barc); 2011 Feb; 136(5):207-14. PubMed ID: 19646718
[No Abstract] [Full Text] [Related]
16. Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine.
Fallahi P; Ferrari SM; Marchi S; De Bortoli N; Ruffilli I; Antonelli A
Endocrine; 2017 Jul; 57(1):175-178. PubMed ID: 27577569
[No Abstract] [Full Text] [Related]
17. Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study.
Fallahi P; Ferrari SM; Antonelli A
Endocrine; 2016 Jun; 52(3):597-601. PubMed ID: 26721663
[TBL] [Abstract][Full Text] [Related]
18. Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009-2015.
Ferrara R; Ientile V; Arcoraci V; Ferrajolo C; Piccinni C; Fontana A; Benvenga S; Trifirò G
Endocrine; 2017 Oct; 58(1):143-152. PubMed ID: 28155170
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
[TBL] [Abstract][Full Text] [Related]
20. Are multisource levothyroxine sodium tablets marketed in Egypt interchangeable?
Abou-Taleb BA; Bondok M; Nounou MI; Khalafallah N; Khalil S
Ann Endocrinol (Paris); 2018 Feb; 79(1):23-29. PubMed ID: 29289332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
